3-Phenyltoxoflavin is primarily explored in the field of biomedical research due to its potential biological activities. It has been studied for its role as an inhibitor of specific enzymes, particularly those involved in cellular signaling pathways. This makes it a candidate for investigating therapeutic strategies in diseases where these pathways are dysregulated, such as certain cancers. Additionally, its structural properties are of interest in the development of novel pharmaceutical compounds, where it may serve as a lead molecule for drug design. Research is ongoing to fully understand its mechanisms and optimize its applications in medicine.